Wasatch Advisors, Inc. has recently announced that it has increased stake in Hamilton Lane Incorporated (NASDAQ:HLNE) by 6.82%. After grabbing 3.31 million shares, the institutional investor is now in possession of 0.21 million shares of the Financial Company. The new investment brought the stake of investor firm to 8.75% having worth around $211.68 million. Moreover, The Vanguard Group, Inc. increased its share by 4276.0 to have a control over 2.96 million shares. And Federated Global Investment Manag raised its holdings to 2100.0 shares by acquiring 1.72 million shares or 4.54% of the stake.
Hamilton Lane Incorporated (HLNE) concluded trading on 01/19/23 at a closing price of $71.79, with 0.15 million shares of worth about $10.74 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 3.01% during that period and on Thursday the price saw a loss of about -0.87%. Currently the company’s common shares owned by public are about 37.01M shares, out of which, 33.46M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 7 analysts are covering the HLNE stock and their offered price forecasts bring an average price target of $72.33. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $86.00 and could fall to a lowest price of $67.00. The stock’s current price level is -0.17% below of average price target set by the analysts, while a dip to estimated low would result in loss of -7.15% for the stock. However, touching the estimated high of $86.00 would mean a gain of 16.52% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 16 times over the past 12 months. They bought 42,763 shares in 10 of the transactions. In 6 selling transactions, insiders dumped 7,832 shares.
Wasatch Core Growth Fund, Federated Hermes Kaufmann Small C, and Vanguard Total Stock Market Index are the top 3 mutual funds which are holding stakes in Hamilton Lane Incorporated Wasatch Core Growth Fund is currently holding 1.17 million shares of worth totaling $74.55 million. The company recently came buying 0.0 shares which brought its stake up to 3.08% of the company’s outstanding shares. Vanguard Total Stock Market Index, after buying 0.96 million shares, have now control over 2.52% of the stake in the company. It holds 1654.0 shares of worth $61.05 million.
Hamilton Lane Incorporated (NASDAQ: HLNE) started trading at $71.72, below -$0.7 from concluding price of the previous day. However, the stock later moved at a day high price of 72.07, or with a loss of -0.87%. Stock saw a price change of 1.56% in past 5 days and over the past one month there was a price change of 6.66%. Year-to-date (YTD), HLNE shares are showing a performance of 12.38% which decreased to -21.18% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $55.81 but also hit the highest price of $92.86 during that period. The average intraday trading volume for Hamilton Lane Incorporated shares is 214.78K. The stock is currently trading 6.69% above its 20-day simple moving average (SMA20), while that difference is up 2.76% for SMA50 and it goes to 4.48% higher than SMA200.
Wasatch Advisors, Inc. acquired 3.31 million shares of Hamilton Lane Incorporated having value of about $211.68 million. Data submitted at the U.S SEC by Wasatch Advisors, Inc. revealed that the firm now holds 0.21 million shares in the company valued at close to $15193420.23, or have control over 6.82% stake in the company. Hamilton Lane Incorporated (NASDAQ: HLNE) currently have 37.01M outstanding shares and institutions hold larger chunk of about 96.30% of that. Holding of mutual funds in the company is about 56.85% while other institutional holders and individual stake holders have control over 6.85% and 35.28% of the stake respectively.
The stock has a current market capitalization of $3.81B and its 3Y-monthly beta is at 1.05. PE ratio of stock for trailing 12 months is 19.55, while it has posted earnings per share of $3.67 in the same period. Its PEG reads 1.30 while making debt-to-equity ratio of 0.50. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HLNE, volatility over the week remained 3.12% while standing at 3.36% over the month.
Analysts are in expectations that Hamilton Lane Incorporated (HLNE) stock would likely to be making an EPS of $0.59 in the current quarter, while forecast for next quarter EPS is $0.76 and it is $3.62 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.51 which is $0.67 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $1.38 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 41.90% while it is estimated to increase by 0.49% in next year. EPS is likely to shrink at an annualized rate of 15.00% for next 5-years, compared to annual growth of 162.50% made by the stock over the past 5-years.
Analysts at 7 brokerage firms have issued recommendations for the Hamilton Lane Incorporated (HLNE)’s stock and average of those rates the stock at a “Hold” and assign it a score of 3.00. Out of those 7 Wall Street analysts, 0 recommended a “Buy” rating, while 7 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on August 09, 2022 offering a Neutral rating for the stock and assigned a target price range of between $72 and $75 to it. Coverage by Wells Fargo stated Hamilton Lane Incorporated (HLNE) stock as an Equal weight in their note to investors on December 16, 2021, suggesting a price target of $109 for the stock. On January 26, 2021, Morgan Stanley Downgrade their recommendations, while on December 16, 2020, UBS Initiated their ratings for the stock with a price target of $83. Stock get a Mkt perform rating from Keefe Bruyette on March 30, 2020.